Typically, RA is treated with steroidal/nonsteroidal anti-inflammatory drugs (NSAID) or biological modulators such as tumor necrosis factor alpha (TNF-α) inhibitors and interleutkin-1 (IL-1) receptor antagonists [3]. Here, TNF is linked to rheumatoid arthritis.